Meine Merkliste
my.bionity.com  
Login  

Fabry disease is a multisystem, X‐linked, lysosomal storage disorder caused by a mutation in the GLA gene on chromosome Xq22 resulting in alpha‐galactosidase A enzyme (α‐Gal A) deficiency. Neurological manifestations other than cerebrovascular accidents include small fibre neuropathy and dysautonomic disorders, which may be the presenting clinical features in a proportion of patients. An atypical disease onset may be misdiagnosed until the emergence of a more typical clinical picture, characterized by chronic renal and cardiac failure. Thus, neurologists should consider Fabry disease in differential diagnosis and provide an appropriate diagnostic work up. This review focuses on central and peripheral nervous system involving available diagnostic tools and diagnostic work up in Fabry disease. It also covers the most recent evidence regarding enzyme replacement therapy.

Autoren:   Bersano, A.; Lanfranconi, S.; Valcarenghi, C.; Bresolin, N.; Micieli, G.; Baron, P.
Journal:   Acta Neurologica Scandinavica
Jahrgang:   2012
Seiten:   n/a
DOI:   10.1111/j.1600-0404.2012.01661.x
Erscheinungsdatum:   19.03.2012

Merkliste

Hier setzen Sie die nebenstehende Fachpublikation auf Ihre persönliche Merkliste.

Zusatzinformationen

Mehr über Wiley
Ihr Bowser ist nicht aktuell. Microsoft Internet Explorer 6.0 unterstützt einige Funktionen auf Chemie.DE nicht.